Clinical Trial Update: A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing basal insulin glargine with exenatide versus basal insulin glargine with bolus insulin lispro, both with metformin, in adults with type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)
• Insulin Glargine (insulin glargine)
• insulin lispro (insulin lispro)
• metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2013-12-17